Gilead Sciences (NQ:GILD)

144.63 -0.11 (-0.08%)

Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Gilead Sciences

< Previous 1 2

...

30 31 32 33 34 35 36 37 38

...

78 79 Next >

Large Cap Biopharmaceuticals Performance ↗

May 20, 2024

The biotech sector remains a laggard YTD as can be seen by the IBB.

Via Talk Markets

Gilead's Recently Acquired Liver Disease Candidate Shows Improvements In Disease Progression And Associated Itch ↗

May 20, 2024

Gilead Sciences reports interim results from the ASSURE study of seladelpar in primary biliary cholangitis, showing significant improvements in cholestasis markers and pruritus.

Via Benzinga

The P3 App: Empowering and Elevating Underprivileged Youth from Socioeconomically Disadvantaged Areas Through Innovative Mentorship

May 18, 2024

CHICAGO - May 18, 2024 - PRLog -- The Pulse of Perseverance alongside Gilead is proud to announce the launch of the P3 mobile app, a pioneering platform unveiled at our signature benefit event on May...

Via PRLog

Investigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and Reduced Itching in Primary Biliary Cholangitis

May 18, 2024

From Gilead Sciences, Inc.

Via Business Wire

Market Whales and Their Recent Bets on GILD Options ↗

May 15, 2024

Via Benzinga

Penny Stock Sleepers: 7 Under-the-Radar Gems Ready to Launch ↗

May 16, 2024

Penny stocks to buy understandably offers many enticing attributes, not least of which is the potential for tremendous returns.

Via InvestorPlace

Kite Data at EHA 2024 Demonstrate Positive Patient Outcomes and Advances in Delivery of CAR T-cell Therapy

May 14, 2024

From Gilead Sciences, Inc.

Via Business Wire

Decoding Gilead Sciences's Options Activity: What's the Big Picture? ↗

May 10, 2024

Via Benzinga

Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program

May 09, 2024

From Gilead Sciences, Inc.

Via Business Wire

Why NASDAQ:GILD qualifies as a good dividend investing stock. ↗

May 09, 2024

Why GILEAD SCIENCES INC (NASDAQ:GILD) is a Top Pick for Dividend Investors.

Via Chartmill

$1000 Invested In This Stock 20 Years Ago Would Be Worth $9,300 Today ↗

May 07, 2024

Via Benzinga

Gilead Sciences Unusual Options Activity For May 06 ↗

May 06, 2024

Via Benzinga

How Is The Market Feeling About Gilead Sciences? ↗

May 06, 2024

Via Benzinga

Biotech Breakthroughs: 3 Stocks on the Verge of Revolutionizing Medicine ↗

May 09, 2024

These biotech breakthrough stocks give investors a glimpse into medicine's future -- and massive moneymaking opportunities to boot.

Via InvestorPlace

Gilead and Kite Oncology to Highlight Broad and Diverse Oncology Portfolio at ASCO 2024

May 07, 2024

From Gilead Sciences, Inc.

Via Business Wire

Bargain Hunting: 7 Stocks Near 52-Week Lows to Buy Before the Bounce Back ↗

May 06, 2024

If you want your shot at significant upside, speculate on these stocks near 52-week lows that can prove the critics wrong.

Via InvestorPlace

Shhh! 3 Secret Biotech Stocks Flying Below Wall Street’s Radar ↗

May 01, 2024

These biotech stocks seem to be rich with intriguing growth plays going for very reasonable multiples this May.

Via InvestorPlace

Gilead Sciences to Present at Upcoming Investor Conferences

April 30, 2024

From Gilead Sciences, Inc.

Via Business Wire

Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week ↗

April 29, 2024

With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages.

Via Benzinga

Topics Stocks

Gilead Sciences Unusual Options Activity ↗

April 26, 2024

Via Benzinga

3 Dividend Stocks to Buy at a 52-Week Low in April ↗

April 26, 2024

Explore these three dividend stocks trading near their 52-week lows, presenting compelling opportunities for income-oriented investors.

Via InvestorPlace

FDA Approves Biktarvy® Label Update With Data for Pregnant Adults With HIV

April 26, 2024

From Gilead Sciences, Inc.

Via Business Wire

Gilead Sciences (GILD) Q1 2024 Earnings Call Transcript ↗

April 25, 2024

GILD earnings call for the period ending March 31, 2024.

Via The Motley Fool

Topics Earnings

GILD Stock Earnings: Gilead Sciences Beats EPS, Beats Revenue for Q1 2024 ↗

April 25, 2024

GILD stock results show that Gilead Sciences beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Will Gilead's Big Veklury Beat Offset A Cancer Drug Miss? ↗

April 25, 2024

Gilead beat first-quarter calls, but it came on the back of Covid drug Veklury.

Via Investor's Business Daily

Gilead Sciences Announces First Quarter 2024 Financial Results

April 25, 2024

From Gilead Sciences, Inc.

Via Business Wire

Stocks Drop, Tech Tumbles With Meta's Weak Outlook, Q1 Stagflation Fears; Gold Miners Advance: What's Driving Markets Thursday? ↗

April 25, 2024

Wall Street suffers a double blow in Thursday’s session, as softer-than-expected revenue forecasts from Meta Platforms Inc. (NASDAQ:META) are being compounded by weaker-than-expected economic growth...

Via Benzinga

Topics Economy

Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields ↗

April 25, 2024

Via Benzinga

US Stocks Brace For Negative Start Amid Tech Earnings Disappointments, Caution Ahead Of Data: 'Worst Of This Two-Week Decline Is Behind Us,' Says Analyst ↗

April 25, 2024

The back-and-forth motion in the market continues, with the index futures pointing to a lower opening on Thursday. Meta Platforms, Inc.’s (NASDAQ:META)

Via Benzinga

Why Is Penny Stock HOOKIPA Pharma Trading Higher On Wednesday? ↗

April 24, 2024

HOOKIPA Pharma secures FDA clearance for its innovative HB-700 therapeutic vaccine targeting KRAS-mutated cancers. Learn about its broad impact on lung, colorectal, and pancreatic cancers, achieving...

Via Benzinga

< Previous 1 2

...

30 31 32 33 34 35 36 37 38

...

78 79 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.